Neuromuscular junction acetylcholinesterase deficiency responsive to albuterol

Pediatric Neurology

Volumn 47, Issue 2, 2012, Pages 137-140

  Chan, Sophelia H S ^a   Wong, Virginia C N ^a   Engel, Andrew G ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SALBUTAMOL;

ACETYLCHOLINESTERASE DEFICIENCY; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; CHILD; CODON; CONGENITAL MYASTHENIC SYNDROME; DRUG DOSE INCREASE; DRUG EFFICACY; ELECTROMYOGRAPHY; EXERCISE TOLERANCE; EXON; FATIGUE; GENE MUTATION; HUMAN; INTELLIGENCE; MALE; MOTOR NERVE; MUSCLE ACTION POTENTIAL; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NERVE STIMULATION; OPHTHALMOPLEGIA; PRIORITY JOURNAL; PTOSIS; SCHOOL CHILD; TREATMENT RESPONSE;

ACETYLCHOLINESTERASE; ALBUTEROL; CHILD; HUMANS; MALE; MYASTHENIC SYNDROMES, CONGENITAL; NEUROMUSCULAR JUNCTION; TREATMENT OUTCOME;

EID: 84863324567     PISSN: 08878994     EISSN: 18735150     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2012.04.022     Document Type: Article

References (15)

1. A.G. Engel, E.H. Lambert, and M.R. Gomez A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release Ann Neurol 1 1977 315 330
2. K. Ohno, J.M. Brengman, A. Tsujino, and A.G. Engel Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme Proc Natl Acad Sci USA 95 1998 9654 9659
3. C. Donger, E. Krejci, and A.P. Serradell Mutation in the human acetylcholinesterase-associated gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency Am J Hum Genet 63 1998 967 975
4. K. Ohno, A.G. Engel, and J.M. Brengman The spectrum of mutations causing endplate acetylcholinesterase deficiency Ann Neurol 47 2000 162 170
5. M. Wang, and A. Marin Characterization and prediction of alternative splice sites Gene 366 2006 219 227
6. A. Jaretzki, R.J. Barohn, and R.M. Ernstoff Myasthenia gravis: Recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America Neurology 55 2000 16 23
7. V. Mihaylova, J.S. Muller, and J.J. Vilchez Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes Brain 131 2008 747 759
8. Y.A. Shapira, M.E. Sadeh, and M.P. Bergtraum Three novel COLQ mutations and variation of phenotypic expressivity due to G240X Neurology 58 2002 603 609
9. K. Ishigaki, D. Nicolle, and E. Krejci Two novel mutations in the COLQ gene causing endplate acetylcholinesterase deficiency Neuromuscul Disord 13 2003 236 244
10. J.S. Müller, S. Petrova, and R. Kiefer Synaptic congenital myasthenic syndrome in three patients due to a novel missense mutation (T441A) of the COLQ gene Neuropediatrics 35 2004 183 189
11. F. Schreiner, M. Hoppenz, R. Klaeren, J. Reimann, and J. Woelfle Novel COLQ mutation 950delC in synaptic congenital myasthenic syndrome and symptomatic heterozygous relatives Neuromuscul Disord 17 2007 262 265
12. M. Bestue-Cardiel, A.S. de-Cabazon-Alvarez, and J.L. Capablo-Liesa Congenital endplate acetylcholinesterase deficiency responsive to ephedrine Neurology 65 2005 144 146
13. D. Lashley, J. Palace, S. Jayawant, S. Robb, and D. Beeson Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7 Neurology 74 2010 1517 1523
14. T. Liewluck, D. Selcen, and A.G. Engel Beneficial effects of albuterol in congenital endplate acetylcholinesterase deficiency and DOK-7 myasthenia Muscle Nerve 44 2011 789 794
15. M. Sadeh, X.-M. Shen, and A.G. Engel Beneficial effect of albuterol in congenital myasthenic syndrome with ε subunit mutations Muscle Nerve 44 2011 289 291